16:31 EDT SciSparc files to sell 21M ordinary shares for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRC:
- SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million
- SciSparc Advances Tourette Syndrome Drug Trial
- SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome
- SciSparc submits IND application to FDA for SCI-110 Phase IIb trial
- SciSparc Ltd. Calls for Crucial Shareholder Votes